Prevalence of and risk factors for osteoporosis and fracture among a male HIV-infected population in the UK
- PMID: 23970632
- PMCID: PMC5362062
- DOI: 10.1177/0956462413492714
Prevalence of and risk factors for osteoporosis and fracture among a male HIV-infected population in the UK
Abstract
Rates of osteoporosis and fracture may be increased in HIV but there are few UK data. Our aim was to examine the prevalence of and risk factors for osteoporosis and fractures among a homogeneous cohort of well-characterized HIV-infected men. In total, 168 men were recruited, median age 45 years, 37 combination antiretroviral therapy (cART) naïve, 46 with <3 years cART exposure and 85 cART-exposed longer term (median >10 years). All participants provided information on bone health and underwent DEXA scanning. Osteopenia was found in 58% of subjects and osteoporosis in 12%; 14% reported fractures since HIV diagnosis. Number of fractures since HIV diagnosis was significantly increased among those with osteoporosis (OR 3.5, 95% CI 1.2-10.4, p = 0.018). Duration of infection greater than 13 years was significantly associated with osteoporosis. Duration of cART was associated in univariate but not multivariate analyses. Strategies to prevent osteoporosis and fractures in HIV will require attention to viral and lifestyle factors and not just cART.
Keywords: DEXA; HIV; Osteoporosis; ageing; antiretroviral therapy; bone density; fractures; male; osteopenia.
Similar articles
-
Evaluation of screening practices for low bone mass and prevalence of osteoporosis and fractures in people living with human immunodeficiency virus attending a sexual health clinic.Intern Med J. 2019 Sep;49(9):1119-1124. doi: 10.1111/imj.14357. Intern Med J. 2019. PMID: 31081166
-
Osteoporosis and osteopenia are not associated with T-cell activation in older cART-treated HIV-infected patients.Neth J Med. 2017 May;75(4):138-144. Neth J Med. 2017. PMID: 28522769
-
Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy.AIDS. 2001 Apr 13;15(6):703-9. doi: 10.1097/00002030-200104130-00005. AIDS. 2001. PMID: 11371684
-
HIV infection and bone disease.J Intern Med. 2016 Oct;280(4):350-8. doi: 10.1111/joim.12520. Epub 2016 Jun 6. J Intern Med. 2016. PMID: 27272530 Review.
-
Protecting bone in long-term HIV positive patients receiving antiretrovirals.Expert Rev Anti Infect Ther. 2016 Jun;14(6):587-99. doi: 10.1080/14787210.2016.1184570. Expert Rev Anti Infect Ther. 2016. PMID: 27189695 Review.
Cited by
-
The effect of anti-retroviral therapy on fracture healing : an in vivo animal model.Bone Joint Res. 2022 Aug;11(8):585-593. doi: 10.1302/2046-3758.118.BJR-2021-0523.R2. Bone Joint Res. 2022. PMID: 35942801 Free PMC article.
-
Serum total estradiol, but not testosterone is associated with reduced bone mineral density (BMD) in HIV-infected men: a cross-sectional, observational study.Osteoporos Int. 2016 Mar;27(3):1103-1114. doi: 10.1007/s00198-015-3383-8. Epub 2015 Oct 28. Osteoporos Int. 2016. PMID: 26510848
-
Pituitary growth hormone (GH) secretion is partially rescued in HIV-infected patients with GH deficiency (GHD) compared to hypopituitary patients.Endocrine. 2017 Mar;55(3):885-898. doi: 10.1007/s12020-016-1133-0. Epub 2016 Oct 11. Endocrine. 2017. PMID: 27730472
-
Bone health and HIV in resource-limited settings: a scoping review.Curr Opin HIV AIDS. 2016 May;11(3):306-25. doi: 10.1097/COH.0000000000000274. Curr Opin HIV AIDS. 2016. PMID: 27023284 Free PMC article.
-
Bone fracture among people living with HIV: A systematic review and meta-regression of prevalence, incidence, and risk factors.PLoS One. 2020 Jun 4;15(6):e0233501. doi: 10.1371/journal.pone.0233501. eCollection 2020. PLoS One. 2020. PMID: 32497105 Free PMC article.
References
-
- WHO Scientific Group on the Prevention and Management of Osteoporosis. Prevention and management of osteoporosis. Geneva, Switzerland: WHO technical report series; 2000. p. 921.
-
- Holroyd C, Cooper C, Dennison E. Epidemiology of osteoporosis. Best Pract Res Clin Endocrinol Metab. 2008;22:671–85. - PubMed
-
- Office of Technology Assessment, US Dept of Commerce. Hip Fracture Outcomes in People Age 50 and Over: Mortality, Service Use, Expenditures, and Long-Term Functional Impairment. Washington, DC: NTIS; 1993. PB94107653.
-
- Cooper C. Epidemiology of osteoporosis. Osteoporos Int. 1999;9(Suppl 2):S2–8. - PubMed
-
- Mallon PW. HIV and bone mineral density. Curr Opin Infect Dis. 2010;23:1–8. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical